| Class / Patent application number | Description | Number of patent applications / Date published |
|---|
| 435364000 | Monkey kidney | 6 |
| 20090246868 | Serum-free vero cell banking process - A serum-free Vero cell banking process provides a standardized and consistent way to generate reliable and stable cell banks for viral vaccine production. The substitution of animal-derived substances with plant-derived substances in the growth and freezing media increases the viability of the cells upon thawing and reduces their recovery time, thereby allowing a more precise schedule for manufacturing and more consistent processes. | 10-01-2009 |
| 20110223659 | Compositions And Methods For Detecting Severe Acute Respiratory Syndrome Coronavirus - The invention provides compositions and methods for detecting the presence of SARS-coronavirus, for screening anti-SARS coronavirus agents and vaccines, and for reducing infection with plus-strand RNA viruses such as SARS-coronavirus. | 09-15-2011 |
| 435365000 | COS (e.g., COS-7, etc.) | 4 |
| 20090047737 | Human LY6-Big Molecules and Methods of Use - The present invention is directed to human Ly6-BIG molecules and their use in diagnostic, prognostic, and treatment methods for colon, lung and other cancers, in preventing the reoccurrence of such cancers, and in diagnostic, prognostic, and treatment methods for autoimmune disorders and AIDS. | 02-19-2009 |
| 20090093052 | Human Hematopoietic Stem And Progenitor Antigen And Methods For Its Use - A hematopoietic progenitor cell antigen and reagents, notably antibodies, that specifically bind to the antigen are provided. Expression of the antigen is highly tissue specific. It is only detected on a subset of hematopoietic progenitor cells derived from human bone marrow, fetal bone marrow and liver, cord blood and adult peripheral blood. The subset of cells recognized by AC133 is CD34 | 04-09-2009 |
| 20130309766 | Endogenous and Non-Endogenous Versions of Human G Protein-Coupled Receptors - The invention disclosed in this patent document relates to transmembrane receptors, more particularly to a human G protein-coupled receptor for which the endogenous ligand is unknown, and to mutated (non-endogenous) versions of the human GPCRs for evidence of constitutive activity. | 11-21-2013 |
| 20140162358 | Endogenous and Non-Endogenous Versions of Human G Protein-Coupled Receptors - The invention disclosed in this patent document relates to transmembrane receptors, more particularly to a human G protein-coupled receptor for which the endogenous ligand is unknown, and to mutated (non-endogenous) versions of the human. GPCRs for evidence of constitutive activity. | 06-12-2014 |
